Voya Investment Management LLC Arcturus Therapeutics Holdings Inc. Transaction History

Voya Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 06, 2024	BUY	$31.23 - $42.99 $240,783 - $331,452	7,710 New	7,710 $260,000
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $55,214 - $76,006	-1,768 Reduced 18.65%	7,710 $260,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $3,240 - $6,033	183 Added 1.97%	9,478 $298,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $10,701 - $14,464	447 Added 5.05%	9,295 $266,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $130,242 - $212,086	8,848 New	8,848 $212,000
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $101,537 - $258,149	-8,282 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $649 - $903	-19 Reduced 0.23%	8,282 $307,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $11,786 - $19,244	-457 Reduced 5.22%	8,301 $281,000
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $26,427 - $59,279	-682 Reduced 7.22%	8,758 $362,000
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $60,152 - $214,921	1,738 Added 22.57%	9,440 $410,000
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $120,080 - $202,397	3,203 Added 71.19%	7,702 $330,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $56,957 - $262,156	4,499 New	4,499 $210,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.